Jakob Dupont Pyxis Oncology, Inc. (PYXS) insider trading activity

PYXS Quotes by TradingView

Jakob Dupont is of Pyxis Oncology, Inc.. Currently has a direct ownership of 38,741 shares of PYXS, which is worth approximately $73,220. The most recent transaction as insider was on Mar 26, 2024, when has been sold 38,741 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.7K
0% 3M change
n/a 12M change
Total Value Held $73,220

Jakob Dupont Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 26 2024
BUY
Grant, award, or other acquisition
-
38,741 Added 50.0%
38,741 Common Stock

Also insider at

ATRA
Atara Biotherapeutics, Inc. Healthcare
EVP, Head of R&D
BCAC
Brookline Capital Acquisition Corp. Financial Services
Director
BOLT
Bolt Biotherapeutics, Inc. Healthcare
JD

Jakob Dupont

South San Francisco, CA

Track Institutional and Insider Activities on PYXS

Follow Pyxis Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PYXS shares.

Notify only if

Insider Trading

Get notified when an Pyxis Oncology, Inc. insider buys or sells PYXS shares.

Notify only if

News

Receive news related to Pyxis Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PYXS